PMCB - PharmaCyte Biotech, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.042
+0.001 (+1.205%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close0.041
Open0.000
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.000 - 0.000
52 Week Range
Volume0
Avg. Volume2,363,604
Market Cap40.87M
Beta2.93
PE Ratio (TTM)N/A
EPS (TTM)-0.010
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire5 days ago

    British Columbia Securities Commission Revokes Cease Trade Order on PharmaCyte Biotech Securities

    PharmaCyte Biotech, Inc. , a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it is providing a summary overview, corporate history and status report to address a regulatory compliance request from the British Columbia Securities Commission which, ...

  • Business Wirelast month

    PharmaCyte Biotech Appoints Dr. Raymond Tong to Board of Directors

    PharmaCyte Biotech, Inc. , a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced the appointment of Dr.

  • We're sorry this is all we were able to find about this topic.